These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1325074)

  • 1. [Detection of antibodies against the hepatitis C virus in Cuban blood donors].
    Rivero RA; Yamaguchi K; Hidalgo-Gato R; Martínez M; Hernández P; Ballester JM
    Sangre (Barc); 1992 Aug; 37(4):301. PubMed ID: 1325074
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antibodies against hepatitis C virus. Study in voluntary blood donors. Cuba 1991].
    Galban García E; Padrón G; Arus Soler E; González O; Rodríguez Z; Mora S; Brito M
    G E N; 1992; 46(1):10-4. PubMed ID: 1339033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The prevalence of antibodies to the hepatitis C virus (HCV) in patients with post-transfusional hepatitis and blood donors in Moldova].
    Iancu L; Turcu T; Apetrei C; Porumb S; Dimitriu S; Donţu G; Mândru R; Moraru E; Duca M
    Bacteriol Virusol Parazitol Epidemiol; 1993; 38(1-2):76-80. PubMed ID: 9132116
    [No Abstract]   [Full Text] [Related]  

  • 4. [The seroprevalence of antibodies against the hepatitis C virus in blood donors at the Hospital Central Militar].
    Hernández-Pérez RE; Frías-Salcedo JA; Del Angel-Guevara O
    Salud Publica Mex; 1994; 36(5):538-40. PubMed ID: 7892629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A seroprevalence study of the hepatitis C virus among multiply transfused patients].
    Antipa C; Popescu A; Teleguţă M; Ruţă S; Cernescu C; Târdei G; Copelovici Y; Stoian M; Tivgă N; Hoinărescu M
    Rev Roum Virol; 1993; 44(1-2):9-15. PubMed ID: 8043483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of hepatitis C virus antibodies in hospital personnel].
    Cağatay M; Tülek N; Köksalan H; Mert A
    Mikrobiyol Bul; 1992 Jul; 26(3):242-7. PubMed ID: 1382216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Seroprevalence of hepatitis C antiviral antibodies in blood donors in N'Djamena (Chad)].
    Massenet D; Djime O
    Bull Soc Pathol Exot; 1993; 86(4):235. PubMed ID: 7507370
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatitis C virus infection among the plasmapheresis donors].
    Wang S; Ding H; Zhang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Apr; 15(2):71-3. PubMed ID: 7522967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibodies against viral hepatitis C in groups at risk].
    Roşiu N; Pop O; Claici C; Cioflec D; Novac VP; Strein R; Nicoară E; Bodea A; Boieriu E; Niculescu V
    Bacteriol Virusol Parazitol Epidemiol; 1994; 39(1-2):84-7. PubMed ID: 7981534
    [No Abstract]   [Full Text] [Related]  

  • 10. [Epidemiological and serological study on hepatitis C virus infection in plasmapheresis donors].
    Sun Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 1991 Dec; 12(6):327-30. PubMed ID: 1667379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of serologic testing for hepatitis C virus infection and risk of posttransfusion hepatitis C.
    Alter MJ
    Arch Pathol Lab Med; 1994 Apr; 118(4):342-5. PubMed ID: 7513149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Different prevalence of hepatopathy among anti-HCV positive blood donors as a function of donation motive].
    Suárez A; Sotorrío NG; Rodríguez M; Rodrigo L
    Med Clin (Barc); 1993 May; 100(19):757. PubMed ID: 8391098
    [No Abstract]   [Full Text] [Related]  

  • 13. Distribution of hepatitis C virus infection in the male Turkish population.
    Coskun O; Erdem H; Besirbellioglu BA; Eyigun CP
    Int J Infect Dis; 2006 Nov; 10(6):481. PubMed ID: 16997590
    [No Abstract]   [Full Text] [Related]  

  • 14. Enzyme-linked immunosorbent assay for antibodies against the capsid protein of hepatitis C virus with a synthetic oligopeptide.
    Okamoto H; Munekata E; Tsuda F; Takahashi K; Yotsumoto S; Tanaka T; Tachibana K; Akahane Y; Sugai Y; Miyakawa Y
    Jpn J Exp Med; 1990 Aug; 60(4):223-33. PubMed ID: 1963454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HCV-positive blood donors. Risk factors].
    Iraporda V; Gil L; Moreda J; Fernández P; González J; Velicia R
    Rev Esp Enferm Dig; 1995 Feb; 87(2):179-80. PubMed ID: 7538317
    [No Abstract]   [Full Text] [Related]  

  • 16. [The clinico-epidemiologic aspects of viral hepatitis C].
    Krylov NL; Ivlev AS; Kalinin AV; Vasil'ev AP; Lytsar' BN
    Voen Med Zh; 1993 Jun; (6):64-7. PubMed ID: 8396287
    [No Abstract]   [Full Text] [Related]  

  • 17. The prevalence of hepatitis C virus antibodies among high risk groups in Thailand.
    Poovorawan Y; Pongpunlert W; Chumdermpadetsuk S; Sakulramrung R; Israsena S
    Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):133-4. PubMed ID: 1658945
    [No Abstract]   [Full Text] [Related]  

  • 18. [Post-transfusion hepatitis C in Finland].
    Ebeling F
    Duodecim; 1993; 109(8):709. PubMed ID: 7520387
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence of antibodies to hepatitis C virus and other markers in Jamaica.
    King SD; Dodd RY; Haynes G; Wynter HH; Sullivan MT; Serjeant GR; Choo-Kang E; Michael E
    West Indian Med J; 1995 Jun; 44(2):55-7. PubMed ID: 7545339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yield of hepatitis C virus nucleic acid testing among antibody-reactive or confirmed-positive samples.
    Schmidt M; Weber M; Busch MP; Tobler LH; Phelps BH; Seifried E; Roth WK
    Transfusion; 2005 Jun; 45(6):1040-2. PubMed ID: 15935008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.